Research of the inhibitory effect and the mechanisms of plumbagin on large cell lung cancer NL9980 cell line
Tao Yu,Kaiyu Li,Ting Gong,Yi Shao,Gang Liu
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2018.02.025
2018-01-01
Abstract:Objective To investigate the effects of plumbagin on human NL9980 large-cell lung cancer cells and the role of interleukin-6/signal transducers and activators of transcription 3 (IL-6/ STAT3) signaling pathway in the anticancer procedure of plumbagin.Methods Different concentrations of plumbagin were administrated in NL9980 cell line.Inhibitory effects of plumbagin on NL9980 cells were analyzed using methyl thiazol tetrazolium (MTT) assay.Groups of different drug doses (5.0,7.5,10.0μmol/L) and blank control (without administration of plumbagin) were set with simple random sampling method.Cells were collected after 24 h of administration.Expression of IL-6 and STAT3 and the downstream genes B-cell lymphoma/leukemia-2 (bcl-2),vascular endothelial growth factor (VEGF),and Cyclin D1 were assessed by real-time quantitative polymerase chain reaction (Real-time PCR).Enzyme linked immunosorbent assay (ELISA) was used to measure secreted IL-6 levels and western blotting to measure intracellular phospho-STAT3 levels.Results Plumbagin significantly inhibited NL9980 cells via suppressing IL-6/STAT3 signaling.Expression of all genes was inhibited by plumbagin in a dose-dependent manner (F =32.170,P =0.000).As the concentration of plumbagin increased,the expression of IL-6 mRNA decreased significantly (F =173.067,P =0.000) to 0.50 ± 0.02,0.44 ± 0.1,0.34 ± 0.04 respectively and IL-6 protein decreased to 4.71 ± 0.02,4.08 ± 0.14,2.01 ± 0.07 significantlly (F =1 805.177,P=0.000).Besides,the expression of STAT3 mRNA (0.86 ±0.08,0.72 ±0.03,0.52 ± 0.06,F=230.918,P=0.000) and protein (0.65 ±0.19,0.45 ±0.22,0.31 ±0.11,F=17.332,P=0.000) were reduced with the increase of concentration of plumbagin.Compared with the control group,expression of downstream genes bcl-2,VEGF and Cyclin D1 mRNA were decreased significantly after administration of plumbagin (F=33.698,P=0.000;F=337.743,P=0.000;F=180.136,P=0.000),and declined gradually as drug concentration increased.Moreover,bcl-2,VEGF,and Cyclin D1 mRNA levels positively correlated with levels of IL-6 and STAT3 gene expressions.Conclusion IL-6-mediated STAT3 suppression decreased bcl-2,VEGF,and Cyclin D1 expression.Thus,plumbagin may be an effective therapy for large-cell lung cancer that acts by targeting the IL-6/STAT3 signaling pathway.